Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC). [electronic resource]
Producer: 20130529Description: 3857-61 p. digitalISSN:- 1872-7727
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Hepatocellular -- diagnostic imaging
- Chemoembolization, Therapeutic -- mortality
- Comorbidity
- Delayed-Action Preparations -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Germany -- epidemiology
- Humans
- Liver Neoplasms -- diagnostic imaging
- Male
- Prevalence
- Risk Factors
- Survival Analysis
- Survival Rate
- Treatment Outcome
- Ultrasonography
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.